the dose-related efficacy and safety of nicardipine , a new calcium antagonist of the dihydropyridine class , was assessed by exercise tolerance testing in a randomized , double-blinded , placebo-controlled study in 19 patients with chronic , stable effort angina pectoris .
C0028005
nicardipine
C0340288
chronic